Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There has never been a ”promise” to anybody to release financials at any time.
There has always been an “anticipation” to release financials at specific times.
Now, we ”hope” financials will be released on/by May 15th just because it fits logically within the SEC schedule.
They would almost have to halt. Then structure the reopening like an IPO...
Uhh...I think you have one too many zeros there, Jerry.
$4,700,000 x 12 = $56,400,000
Yes, May 15th is during the second quarter. May 15th also happens to be the deadline for Non-accelerated filers for filing first quarter financials.
I still don’t have a clue when fins will drop...
All tweets are true until proven false!
Onus is on the disbelievers!
Innocent until proven guilty...
They've added almost $2,000,000 a week in clinical testing services.
Can't argue with that!
Tweets are proof enough.
If not true, the company has committed blatant fraud.
Easy law suit and jail time.
SEC guidance recognizes all tweets by corporations as valid communication to shareholders/public.
There is no loophole for this.
2019 SEC Filing Deadlines and Holidays
https://www.broadridge.com/_assets/pdf/broadridge-edgar-filing-calendar-2019.pdf
Non-accelerated filers deadline for first quarter 10Q is Wednesday, May 15th.
So much going on behind the scenes!
THEY TWEET ONLY A FRACTION OF THEIR BUSINESS!!
Their revenue streams are enormous!
BIG BUCKS EVERY WEEK!!
Looks like the 1,700 reps they have under contract are doing their jobs.
Nice screenshot of Arrayit allergy documentation in that video.
https://photos.app.goo.gl/RjJEdnPQfhNybKjD7
All credible companies, and incredible companies, (like Arrayit), may choose to make announcements through Twitter, at their discretion.
Tweets are official documentation.
SEC Says Social Media OK for Company Announcements if Investors Are Alerted
FOR IMMEDIATE RELEASE
2013-51
Washington, D.C., April 2, 2013 —
The Securities and Exchange Commission today issued a report that makes clear that companies can use social media outlets like Facebook and Twitter to announce key information in compliance with Regulation Fair Disclosure (Regulation FD) so long as investors have been alerted about which social media will be used to disseminate such information.
The SEC’s report of investigation confirms that Regulation FD applies to social media and other emerging means of communication used by public companies the same way it applies to company websites. The SEC issued guidance in 2008 clarifying that websites can serve as an effective means for disseminating information to investors if they’ve been made aware that’s where to look for it. Today’s report clarifies that company communications made through social media channels could constitute selective disclosures and, therefore, require careful Regulation FD analysis.
https://www.sec.gov/news/press-release/2013-2013-51htm
Love those clinical testing services sales! BIG MONEY!!
When these guys go current, it's going to be EPIC!
As in, never seen before!
Another Arrayit and the United States Department of Agriculture
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform
Beatriz Quiñones 1,*, Bertram G. Lee 1, Todd J. Martinsky 2, Jaszemyn C. Yambao 1, Paul K. Haje 2 and Mark Schena 2
1 U.S. Department of Agriculture, Agricultural Research Service, Western Regional Research Center, Produce Safety and Microbiology Unit, Albany, CA 94710, USA
2 Arrayit Corporation, Sunnyvale, CA 94085, USA
*
Author to whom correspondence should be addressed.
Received: 20 July 2017 / Revised: 15 September 2017 / Accepted: 18 September 2017 / Published: 20 September 2017
(This article belongs to the Special Issue Sensors for Toxic and Pathogen Detection)
https://doi.org/10.3390/s17092157
Arrayit and the United States Department of Agriculture
Agricultural Research Service
Research Project: Molecular Identification and Characterization of Bacterial and Viral Pathogens Associated with Foods
Location: Produce Safety and Microbiology Research
Project Number: 2030-42000-051-00-D
Project Type: In-House Appropriated
Start Date: Feb 25, 2016
End Date: Feb 24, 2021
Approach:
Objective 1: A fast, simple and high throughput array-based method for typing pathogens will be developed. Capture probes will be designed to target norovirus and hepatitis A virus, clinically-important Salmonella serovars and Campylobacter spp. To evaluate probe specificity, viral RNA or bacterial DNA will be extracted from clinical samples or cultured strains. A Cooperative Research and Development Agreement (CRADA) has been established with Arrayit Corporation to develop a fast, simple, and cost-effective test, in conjunction with inexpensive instrumentation.
https://www.ars.usda.gov/research/project/?accnNo=430420
Thanks to Lizzybird! I just followed with a little curious investigation. I believe they call it DD...
MDPI (Molecular Diversity Preservation International)
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform
Beatriz Quiñones 1,*, Bertram G. Lee 1, Todd J. Martinsky 2, Jaszemyn C. Yambao 1, Paul K. Haje 2 and Mark Schena 2
1U.S. Department of Agriculture, Agricultural Research Service, Western Regional Research Center, Produce Safety and Microbiology Unit, Albany, CA 94710, USA
2Arrayit Corporation, Sunnyvale, CA 94085, USA
*
Author to whom correspondence should be addressed.
Received: 20 July 2017 / Revised: 15 September 2017 / Accepted: 18 September 2017 / Published: 20 September 2017
https://www.mdpi.com/1424-8220/17/9/2157
United States Department of Agriculture
Agricultural Research Service
Research Project: Molecular Identification and Characterization of Bacterial and Viral Pathogens Associated with Foods
Location: Produce Safety and Microbiology Research
Title: Sensitive genotyping of foodborne-associated human noroviruses and hepatitis A virus using an array-based platform
Author
Quiñones, Beatriz
Lee, Bertram
Martinsky, Todd - Arrayit Corporation
Yambao, Jaszemyn
Haje, Paul - Arrayit Corporation
Schena, Mark - Arrayit Corporation
[b[Submitted to: Sensors
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 9/18/2017
Publication Date: 9/20/2017
Citation: Quinones, B., Lee, B.G., Martinsky, T.J., Yambao, J.C., Haje, P.K., Schena, M. 2017. Sensitive genotyping of foodborne-associated human noroviruses and hepatitis A virus using an array-based platform. Sensors. 17(9):2157. https://doi.org/10.3390/s17092157.
DOI: https://doi.org/10.3390/s17092157
United States Department of Agriculture
Agricultural Research Service
Research Project: Molecular Identification and Characterization of Bacterial and Viral Pathogens Associated with Foods
Location: Produce Safety and Microbiology Research
Project Number: 2030-42000-051-00-D
Project Type: In-House Appropriated
Start Date: Feb 25, 2016
End Date: Feb 24, 2021
Approach:
Objective 1: A fast, simple and high throughput array-based method for typing pathogens will be developed. Capture probes will be designed to target norovirus and hepatitis A virus, clinically-important Salmonella serovars and Campylobacter spp. To evaluate probe specificity, viral RNA or bacterial DNA will be extracted from clinical samples or cultured strains. A Cooperative Research and Development Agreement (CRADA) has been established with Arrayit Corporation to develop a fast, simple, and cost-effective test, in conjunction with inexpensive instrumentation.
FDA does not "buy" equipment to test. They are given the equipment to test.
Can you imagine the hundreds of millions of dollars they would be spending just to test everybody's equipment?
Jason Nielson took profits.
30,643.345 shares sold, almost 22% of his holdings.
All sold between .04 and .06
Wasn’t any part of a drop.
Looks like he was considerate in his selling.
Still has 112,000,000 shares.
30,643.345 shares sold, almost 22% of his holdings.
All sold between .04 and .06
Wasn’t any part of a drop.
Looks like he was considerate in his selling.
Still has 112,000,000 shares.
12 form 4s so far.
22,203,249 shares sold.
Almost 16% of his holdings.
Preferred shares are usually used for BODs....
Scam companies don't get selected for the top 10...
Arrayit selected as a top 10 In-Vitro Diagnostic Technology Solution Provider for 2019 by healthcare intelligence leaders Medtech Outlook HQ in Northern California USA and connecting providers and payers in the massive $3 trillion US healthcare markets https://t.co/LV0biboB86 https://t.co/4dL1lplgFR
I’m guessing Ochsner. It’s right there on the site. All folks have to do is watch the video.
“This new partnership leverages the widely used Apple iPad platform and iPhone operating system (iOS) to streamline key aspects of Arrayit doctor-prescribed allergy testing services including patient scheduling, test kit ordering, electronic retrieval of test results and requests for ancillary treatment options, all in manner this is fully compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA).“
https://www.apple.com/healthcare/
OTCX on board with a $25.00 Ask
Refer to post #124203 from HighYieldStocks
Comprehensive DD compiled from all the Longs.
Dive in...
2019 SEC FILING DEADLINES shows a non-accelerated filer has April 1st as the deadline to file a 10K.
Seems they have the entire weekend to file.
12 Company Profiles (Page No. - 84)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Thermo Fisher Scientific
12.2 Agilent Technologies
12.3 Illumina
12.4 Perkinelmer, Inc.
12.5 Merck KGaA
12.6 GE Healthcare
12.7 Molecular Devices (A Subsidiary of Danaher)
12.8 Arrayit Corporation
12.9 Bio-Rad Laboratories
12.10 Microarrays, Inc.
https://www.marketsandmarkets.com/Market-Reports/microarray-analysis-market-55253403.html
Hard to say there's not manipulation going on here. They do not want to let this run...
Mr. Nielsen’s stock position now worth $19,037,418.00...WOW!
https://www.sec.gov/Archives/edgar/data/1084507/000173493518000005/xslF345X03/primary_doc.xml
The letter to shareholders states we have a Board of Directors now. That’s new and I didn’t catch that when the letter was first released. We have to have a Board to uplist to NASDAQ so it’s good to know that’s been taken care of.
Wonder who they are...
Nice find. Good to see active marketing for our product!
Now why would they be invited to this, way off in December? Hmmm...
“Arrayit CLIA clinical team invited to the prestigious healthcare conference 1st Annual International Congress of Cancer & Clinical Oncology December 5-7 2019 in Singapore showcasing premium testing opportunities in the massive global clinical markets istci.org/ccco2019/“
Yes, it would.
But I suspect they won’t release that announcement until the night before or the morning of. People will have little to no time to make a decision to buy. The price action will be so fast it will be beyond peoples’ bids.
Then possibly a temporary halt in trading to sort things out.